129 related articles for article (PubMed ID: 2296889)
1. Value of programmed ventricular stimulation in the evaluation and management of patients with nonsustained ventricular tachycardia associated with coronary artery disease.
Manolis AS; Estes NA
Am J Cardiol; 1990 Jan; 65(3):201-5. PubMed ID: 2296889
[TBL] [Abstract][Full Text] [Related]
2. Risk stratification and management of patients with organic heart disease and nonsustained ventricular tachycardia: role of programmed stimulation, left ventricular ejection fraction, and the signal-averaged electrocardiogram.
Turitto G; Fontaine JM; Ursell S; Caref EB; Bekheit S; el-Sherif N
Am J Med; 1990 Jan; 88(1N):35N-41N. PubMed ID: 2368762
[TBL] [Abstract][Full Text] [Related]
3. Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study.
Buxton AE; Marchlinski FE; Flores BT; Miller JM; Doherty JU; Josephson ME
Circulation; 1987 Jun; 75(6):1178-85. PubMed ID: 3568327
[TBL] [Abstract][Full Text] [Related]
4. Value of electrophysiologic testing in patients with previous myocardial infarction and nonsustained ventricular tachycardia. Philadelphia Arrhythmia Group.
Kowey PR; Waxman HL; Greenspon A; Greenberg R; Poll D; Kutalek S; Gessman L; Muenz L
Am J Cardiol; 1990 Mar; 65(9):594-8. PubMed ID: 2309629
[TBL] [Abstract][Full Text] [Related]
5. Conversion of sustained into nonsustained ventricular tachycardia during therapy assessment by programmed ventricular stimulation: criterion for a positive drug effect?
Schoels W; Brachmann J; Schmitt C; Waldecker B; Kuebler W
Am J Cardiol; 1989 Aug; 64(5):329-34. PubMed ID: 2756877
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiologic and electrocardiographic effects, efficacy and safety of encainide in malignant ventricular arrhythmias associated with coronary artery disease.
Weintraub AR; Manolis AS; Estes NA
Am J Cardiol; 1990 Oct; 66(12):947-53. PubMed ID: 2121017
[TBL] [Abstract][Full Text] [Related]
7. Management of nonsustained ventricular tachycardia guided by electrophysiological testing.
Kadish A; Schmaltz S; Calkins H; Morady F
Pacing Clin Electrophysiol; 1993 May; 16(5 Pt 1):1037-50. PubMed ID: 7685883
[TBL] [Abstract][Full Text] [Related]
8. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
[TBL] [Abstract][Full Text] [Related]
9. Use of isoproterenol during programmed ventricular stimulation in patients with coronary artery disease and nonsustained ventricular tachycardia.
Niebauer M; Daoud E; Goyal R; Chan KK; Harvey M; Bogun F; Castellani M; Man KC; Strickberger SA; Morady F
Am Heart J; 1996 Mar; 131(3):516-8. PubMed ID: 8604631
[TBL] [Abstract][Full Text] [Related]
10. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia.
Grimm W; Hoffmann J; Menz V; Luck K; Maisch B
J Am Coll Cardiol; 1998 Sep; 32(3):739-45. PubMed ID: 9741521
[TBL] [Abstract][Full Text] [Related]
11. Reproducibility of programmed electrical stimulation responses in patients with ventricular tachycardia or fibrillation associated with coronary artery disease.
Volgman AS; Zheutlin TA; Mattioni TA; Parker MA; Kehoe RF
Am J Cardiol; 1992 Sep; 70(7):758-63. PubMed ID: 1519526
[TBL] [Abstract][Full Text] [Related]
12. Influence of ventricular function and presence or absence of coronary artery disease on results of electrophysiologic testing for asymptomatic nonsustained ventricular tachycardia.
Hammill SC; Trusty JM; Wood DL; Bailey KR; Vatterott PJ; Osborn MJ; Holmes DR; Gersh BJ
Am J Cardiol; 1990 Mar; 65(11):722-8. PubMed ID: 2316454
[TBL] [Abstract][Full Text] [Related]
13. Results of electrophysiological testing and long-term follow-up in patients sustaining cardiac arrest only while receiving type IA antiarrhythmic agents.
Hook BG; Rosenthal ME; Marchlinski FE; Buxton AE; Josephson ME
Pacing Clin Electrophysiol; 1992 Mar; 15(3):324-33. PubMed ID: 1372727
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility of ventricular tachycardia suppression by antiarrhythmic drug therapy during serial electrophysiologic testing in coronary artery disease.
Garan H; Stavens CS; McGovern B; Kelly E; Ruskin JN
Am J Cardiol; 1986 Nov; 58(10):977-80. PubMed ID: 3776854
[TBL] [Abstract][Full Text] [Related]
15. Results and efficiency of programmed ventricular stimulation with four extrastimuli compared with one, two, and three extrastimuli.
Hummel JD; Strickberger SA; Daoud E; Niebauer M; Bakr O; Man KC; Williamson BD; Morady F
Circulation; 1994 Dec; 90(6):2827-32. PubMed ID: 7994827
[TBL] [Abstract][Full Text] [Related]
16. Nonischemic ventricular tachycardia. Clinical course and long-term follow-up in patients without clinically overt heart disease.
Lemery R; Brugada P; Bella PD; Dugernier T; van den Dool A; Wellens HJ
Circulation; 1989 May; 79(5):990-9. PubMed ID: 2713978
[TBL] [Abstract][Full Text] [Related]
17. Value of programmed ventricular stimulation in predicting sudden death and sustained ventricular tachycardia in survivors of acute myocardial infarction.
Zoni-Berisso M; Molini D; Mela GS; Vecchio C
Am J Cardiol; 1996 Apr; 77(9):673-80. PubMed ID: 8651115
[TBL] [Abstract][Full Text] [Related]
18. Programmed electrical stimulation and long-term follow-up in asymptomatic, nonsustained ventricular tachycardia.
Veltri EP; Platia EV; Griffith LS; Reid PR
Am J Cardiol; 1985 Aug; 56(4):309-14. PubMed ID: 4025171
[TBL] [Abstract][Full Text] [Related]
19. The signal averaged electrocardiogram and programmed stimulation in patients with complex ventricular arrhythmias.
Turitto G; el-Sherif N
Pacing Clin Electrophysiol; 1990 Dec; 13(12 Pt 2):2156-9. PubMed ID: 1704610
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone.
Manolis AS; Uricchio F; Estes NA
Am J Cardiol; 1989 May; 63(15):1052-7. PubMed ID: 2705375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
